gvtcx

NHS National Framework Agreement - Inhalation Anaesthetics and Vaporisers

Medicines Procurement and Supply Chain (MPSC) Published 31 Mar 2025 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£8,866,189
Statuscomplete
Category (CPV) 33600000
Deadline11 Dec 2024
Contract start1 Feb 2025
Contract end31 Jan 2027
Procedureopen
SME suitableYes
OCIDocds-b5fd17-ea0142bf-89c3-4d7b-b97a-296873fe1457

Awards (3)

This procurement was awarded to 3 suppliers. Values shown are per-award; the notice total is £8,866,189.

SupplierValueDateStatus
Abbvie Ltd shared £36,522,476 24 Jan 2025 active
Baxter Healthcare Ltd shared £36,522,476 24 Jan 2025 active
Piramal Critical care Limited shared £36,522,476 24 Jan 2025 active

description

NHS National Framework Agreement - Inhalation Anaesthetics and Vaporisers

Period of framework agreement: 1st February 2025 to 31st January 2027, with an option or options to extend (at the discretion of the Authority) for a period or periods of up to 24 months. with option or options to extend (at the discretion of the Authority) for a period or periods of up to 24 months.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
31 Mar 2025 Award (award) · 1c5ea426-1327-4f84-917d-042a62442272-837454

more from Medicines Procurement and Supply Chain (MPSC)

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.